HAVCR2 and hematologic disorder: Numerous studies have shown that high TIM-3 expression is associated with poor prognosis in solid tumors and hematologic malignancies, and is closely linked to processes such as maintenance of tumor stem cells, remodeling of the tumor microenvironment, and immune depletion (6–8).